Workflow
Supernus Pharmaceuticals, Inc. (SUPN) Hit a 52 Week High, Can the Run Continue?

A strong stock as of late has been Supernus Pharmaceuticals (SUPN) . Shares have been marching higher, with the stock up 5.7% over the past month. The stock hit a new 52-week high of $47.07 in the previous session. Supernus has gained 29.9% since the start of the year compared to the -1.8% move for the Zacks Medical sector and the -2.2% return for the Zacks Medical - Generic Drugs industry.What's Driving the Outperformance?The stock has a great record of positive earnings surprises, as it hasn't missed our ...